States » SouthPosted at: Jul 1 2025 12:48AM


BE partners with Chinese innovative vaccine firm Recbio to produce HPV9 vaccine

Hyderabad, June 30 (UNI) Jiangsu Recbio Technology Company Limited, a leading Chinese biopharmaceutical company, today announced they have entered into a licensing cooperation agreement, and commenced the technology transfer of their Recombinant 9-valent HPV (HPV9) vaccine, REC603, to Biological E. Limited (BE), a leading Indian vaccine and pharmaceutical company.
Recbio will provide BE with Drug Substance (DS) and transfer technology to formulate, fill, and package vaccines. It will also include technology transfer for DS production at an appropriate time in the future, a release said here.
According to the agreement, BE, a Hyderabad based vaccine maker, will receive the exclusive right to commercialize the vaccine in India and participate in UNICEF & PAHO tenders in other markets.
The HPV9 vaccine is a recombinant vaccine designed to protect against nine types of Human Papillomavirus (HPV), including those responsible for cervical, vulvar, vaginal, anal, and oropharyngeal cancers, as well as genital warts.
HPV is a group of over 200 known viruses, some of which are classified as high-risk due to their potential to cause cancer.
While most HPV infections are controlled by the body's immune system, persistent infections with high-risk HPV types can lead to cervical cancer and other malignancies affecting the vulva, vagina, mouth, throat, penis, and anus.
In 2019 alone, HPV was linked to an estimated 620,000 cancer cases in women and 70,000 in men. Preventive vaccination, alongside HPV screening and treatment of pre-cancerous lesions, is a key strategy in reducing the global burden of HPV-related cancers.
Cervical cancer is the fourth leading cause of cancer-related deaths among women worldwide. The 9-valent HPV vaccine is effective in preventing around 90 percent of cervical cancer and 90 percent of anal and genital warts. Recbio's core product, REC603, is for people ranging from 9 to 45 years old and is currently in the crucial Phase III clinical trials in China.
Following the signing of the technology license agreement, Recbio has begun transferring the necessary technical knowledge, materials, and expertise to BE to produce the HPV9 vaccine. Recbio will continue to support BE in clinical development and regulatory approvals to ensure a seamless transition.
This collaboration comes at a crucial time, as the global demand for cervical cancer prevention is at an all-time high.
By leveraging BE’s advanced manufacturing capabilities, this partnership aims to increase the availability of an affordable HPV9 vaccine in India and across international markets.
BE will begin large-scale manufacturing of the HPV9 vaccine once the Technology transfer is completed.
This collaboration marks a significant milestone for Recbio in entering the Indian and international markets, highlighting its potential in the innovative vaccine field.
Dr. Liu Yong, Founder, Chairman, and CEO of Recbio, stated, " This cooperation is another significant progress for Recbio in expanding into international markets., We will work together with our Indian partner to accelerate the launch process of the HPV9 vaccine in India, and jointly make greater contributions to global public health."
Ms. Mahima Datla, Managing Director, Biological E. Limited, said: “This collaboration aligns with our commitment to improving global health by making essential vaccines more accessible and affordable as well as to promote a lasting legacy of innovation and stewardship. We, along with Recbio, are committed to creating a healthier and more robust future by ensuring that this life-saving vaccine is delivered to those who need it the most.”
UNI KNR RN
Tags: #BE partners with Chinese innovative vaccine firm Recbio to produce HPV9 vaccine
More News

SKM, trade unions call for nationwide strike on Jul 9

03 Jul 2025 | 3:14 PM

Hyderabad, July 3 (UNI) Leaders of the Samyukta Kisan Morcha (SKM) and central trade unions have called for a nationwide strike on July 9 to protest the Modi government’s "anti-farmer, anti-labour and anti-people" policies.

see more..

No link yet between Covid vaccine and Hassan deaths: ICMR

03 Jul 2025 | 1:44 PM

Bengaluru, July 3 (UNI) Amid rising concern over a surge in sudden deaths — nearly 70 reported in Karnataka’s Hassan district over the past two months — Dr Manoj V Murhekar, senior scientist at the Indian Council of Medical Research today clarified that current scientific evidence does not link COVID-19 vaccination to such fatalities.

see more..
Fire near Govindarajaswamy temple in Tirupati; two shops gutted

Fire near Govindarajaswamy temple in Tirupati; two shops gutted

03 Jul 2025 | 12:39 PM

Tirupati, July 3 (UNI) A major fire broke out near the premises of the famous Govindarajaswamy temple in Tirupati today morning.

see more..
Major fire near Govindarajaswamy temple in Tirupati; two shops gutted

Major fire near Govindarajaswamy temple in Tirupati; two shops gutted

03 Jul 2025 | 12:37 PM

Tirupati, July 3 (UNI) A major fire broke out near the premises of the famous Govindarajaswamy Temple in Tirupati on Thursday morning.

see more..
Dubey claims Shivakumar to replace Siddaramaiah in Nov

Dubey claims Shivakumar to replace Siddaramaiah in Nov

03 Jul 2025 | 12:36 PM

Bengaluru, July 3 (UNI) BJP MP Dr Nishikant Dubey today claimed that a leadership change has already been finalised within the Karnataka Congress, alleging that DK Shivakumar will replace Siddaramaiah as Chief Minister by November this year.

see more..